GM 608

· Genervon Biopharmaceuticals, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GM 608, covering 2019-08-08 to 2019-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease [Phase 2]